跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Degrader 2
首页
药物
Degrader 2
Degrader 2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS AND THEIR DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
EP 4228757 B1
申请人: SANOFI SA
优先权: 2020
EP
US
WO
4 件公开
EP 4228758 C0
申请人: SANOFI SA
优先权: 2020
EP
US
WO
4 件公开
CHIMERIC CONJUGATES FOR DEGRADATION OF VIRAL AND HOST PROTEINS AND METHODS OF USE
EP 4228699 A1
申请人: DANA FARBER CANCER INST INC
优先权: 2020
EP
US
WO
3 件公开
METHODS AND COMPOSITIONS FOR TREATING CANCER
EP 4618992 A1
申请人: ONCONOVA THERAPEUTICS INC
优先权: 2022
EP
US
WO
3 件公开
Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for Their Preparation and Therapeutic Uses Thereof
US 2023115865 A1
申请人: SANOFI SA
优先权: 2019
EP
US
3 件公开
MOLECULAR GLUE DEGRADERS AND USES THEREOF
EP 4766708 A1
申请人: MABLINK BIOSCIENCE
优先权: 2023
EP
WO
3 件公开
NOVEL SUBSTITUTED QUINOLINE AND TETRAHYDRONAPHTHALENE CARBOXYLIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF
US 20260055080 A1
申请人: SANOFI
优先权: 2022
US
WO
2 件公开
BCL-2/BCL-XL PROTEIN DEGRADER AND USE THEREOF
EP 4719408 A1
申请人: ASCENTAGE PHARMA SUZHOU CO LTD
优先权: 2023
EP
WO
2 件公开
WO 2026114258 A1
申请人: ASCENTAGE PHARMA SUZHOU CO LTD
优先权: 2024
WO
PROTEIN TYROSINE PHOSPHATASE DEGRADERS AND USES THEREOF
EP 4754097 A2
申请人: NERIO THERAPEUTICS INC
优先权: 2023
EP
WO
2 件公开
COMPOUND AND USE THEREOF
EP 4763838 A1
申请人: OCEAN UNIV CHINA
优先权: 2023
CN
EP
2 件公开
A CRYSTALLINE FORM OF 6-FLUORO-3-(2,4,5-TRIFLUORO-3-METHOXYPHENYL)-1-BENZOTHIOPHENE-2-CARBOXYLIC ACID
EP 4805088 A1
申请人: PFIZER
优先权: 2023
EP
WO
2 件公开
第 1 / 3 页
上一页
下一页
药物
反馈